Holen Sie sich die Stockscreener-App
53.93
4.67%
-2.64
Schlusskurs vom Vortag:
$56.57
Offen:
$56.33
24-Stunden-Volumen:
20.83M
Relative Volume:
1.17
Marktkapitalisierung:
$80.16B
Einnahmen:
$20.62B
Nettoeinkommen (Verlust:
$3.56B
KGV:
22.62
EPS:
2.3847
Netto-Cashflow:
$3.48B
1W Leistung:
-4.55%
1M Leistung:
-13.79%
6M Leistung:
-46.08%
1J Leistung:
-47.79%
1-Tages-Spanne:
$53.63
$56.62
1-Wochen-Bereich:
$53.63
$58.18
52-Wochen-Spanne:
$53.63
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
53.93 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
84.32 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
285.47 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
76.15 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
EW
Edwards Lifesciences Corp
|
79.96 | 46.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-30 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | Herabstufung | Erste Group | Buy → Hold |
| 2025-09-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Boston Scientific Corp. stock (US10117L1017): Shares hit 52-week low after earnings beat and guidanc - AD HOC NEWS
Boston Scientific Corp (BSX) Stock Down 4.7% -- Now Undervalued? GF Score: 84/100 - GuruFocus
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Endeavor plans to redevelop 24-acre Boston Scientific campus in Minnetonka - The Business Journals
Boston Scientific’s pacemaker recall is most serious type: FDA - Modern Healthcare News
Fund Update: 191,081 BOSTON SCIENTIFIC (BSX) shares added to Glenview Trust Co portfolio - Quiver Quantitative
Boston Scientific principal’s advice: ‘Build the doors you want to walk through’ - The Business Journals
Boston Scientific Corp. Stock (US10117L1017): Hits 52-Week Low Amid Analyst Downgrades and Guidance - AD HOC NEWS
Boston Scientific Announces Software Upgrade for Pacemakers Amid Recall - GuruFocus
US FDA issues recall of Boston Scientific heart devices - Reuters
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Penumbra shareholders approve merger with Boston Scientific - Investing.com
Fund Update: 543,460 BOSTON SCIENTIFIC (BSX) shares added to Mawer Investment Management Ltd. portfolio - Quiver Quantitative
FMR LLC updates Boston Scientific holding (NYSE: BSX) — 75.8M shares - Stock Titan
Do Boston Scientific's (NYSE:BSX) Earnings Warrant Your Attention? - Yahoo Finance
BSX Technical Analysis | Trend, Signals & Chart Patterns | BOSTON SCIENTIFIC CORP (NYSE:BSX) - ChartMill
Boston Scientific Corporation Restated Certificate of Incorporation: Key Provisions, Director Rights, and Shareholder Protections - Minichart
Boston Scientific shareholders approve charter amendments and board elections By Investing.com - Investing.com Canada
Boston Scientific shareholders approve charter amendments and board elections - Investing.com
Boston Scientific (NYSE: BSX) investors approve charter changes and board slate - Stock Titan
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Boston Scientific stock hits 52-week low at 56.04 USD By Investing.com - Investing.com UK
Boston Scientific stock hits 52-week low at 56.04 USD - Investing.com
Boston Scientific (BSX) EVP manages tax on 1,802 RSU vesting - Stock Titan
Boston Scientific (NYSE: BSX) EVP exercises RSUs and withholds shares for taxes - Stock Titan
BSX Stock Quote Price and Forecast - CNN
BSX FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - Business Wire
Penumbra earnings in focus as Boston Scientific deal looms - Investing.com
BSX DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionBSX - TMX Newsfile
Piper Sandler reiterates Boston Scientific stock rating on survey - Investing.com
Boston Scientific maps out May conference appearance, July 29 Q2 call - Stock Titan
Boston Scientific announces participation in Bernstein's 42nd Annual Strategic Decisions Conference and conference call discussing second quarter 2026 results - ChartMill
BSX Stock Price, Quote & Chart | BOSTON SCIENTIFIC CORP (NYSE:BSX) - ChartMill
Penobscot Investment Management Company, Inc.'s Boston Scientific Corp(BSX) Holding History - GuruFocus
BSX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important May 4 Deadline in Securities Class ActionBSX - Scott Coop
Bronstein, Gewirtz & Grossman LLC Urges Boston Scientific Corporation Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
BSX Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Boston Scientific Corporation (NYSE:BSX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Boston Scientific Corp. Opens with 4.84% Gain, Outperforming S&P 500's 1.05% Increase - Markets Mojo
BSX Deadline: BSX Investors Have Opportunity to Lead Boston Scientific Corporation Securities Fraud Lawsuit - ChartMill
Boston Scientific Corporation (BSX): Billionaire Tom Steyer Is Loading Up on This Stock - Insider Monkey
BSX 72 HOUR DEADLINE REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - marketscreener.com
Boston Scientific AGM: $20B 2025 Sales, Governance Votes Pass, Special Meeting Proposals Fail - Yahoo Finance
Boston Scientific Q1 2026 Financial Results: Earnings, Risk Factors, and Comprehensive Performance Overview - Minichart
Teza Capital Management LLC's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific Corp 1Q 2026: Revenue $5.2B, EPS $0.9— 10-Q Summary - TradingView
BSX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Boston Scientific (BSX) Investors of Securities Class Action Deadline on May 4, 2026 - ChartMill
Wall Street Analysts Think Boston Scientific (BSX) Is a Good Investment: Is It? - Yahoo Finance
Inside Boston Scientific's $15 billion offer for Alameda's largest employer - The Business Journals
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
Oppenheimer Asset Management Inc. Sells 21,543 Shares of Boston Scientific Corporation $BSX - MarketBeat
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.32%
3.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):